Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitlePhase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.AuthorsNewland, Adrian C.; Sánchez‐González, Blanca; Rejtő, László; Egyed, Miklos; Romanyuk, Nataliya; Godar, Marie; Verschueren, Katrien; Gandini, Domenica; Ulrichts, Peter; Beauchamp, Jon; Dreier, Torsten; Ward, E. Sally; Michel, Marc; Liebman, Howard A.; Haard, Hans; Leupin, Nicolas; Kuter, David J.PublicationAmerican Journal of Hematology, 2020, Vol 95, Issue 2, p178ISSN0361-8609Publication typeArticleDOI10.1002/ajh.25680